University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
David Hage Publications

Published Research - Department of Chemistry

6-1-2009

Measurement Of Drug-Protein Dissociation Rates By HighPerformance Affinity Chromatography And Peak Profiling
John E Schiel
University of Nebraska - Lincoln

Corey M. Ohnmacht
University of Nebraska - Lincoln

David S. Hage
University of Nebraska-Lincoln, dhage1@unl.edu

Follow this and additional works at: https://digitalcommons.unl.edu/chemistryhage

Schiel, John E; Ohnmacht, Corey M.; and Hage, David S., "Measurement Of Drug-Protein Dissociation
Rates By High-Performance Affinity Chromatography And Peak Profiling" (2009). David Hage Publications.
24.
https://digitalcommons.unl.edu/chemistryhage/24

This Article is brought to you for free and open access by the Published Research - Department of Chemistry at
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in David Hage Publications by
an authorized administrator of DigitalCommons@University of Nebraska - Lincoln.

NIH Public Access
Author Manuscript
Anal Chem. Author manuscript; available in PMC 2012 September 17.

NIH-PA Author Manuscript

Published in final edited form as:
Anal Chem. 2009 June 1; 81(11): 4320–4333. doi:10.1021/ac9000404.

MEASUREMENT OF DRUG-PROTEIN DISSOCIATION RATES BY
HIGH-PERFORMANCE AFFINITY CHROMATOGRAPHY AND
PEAK PROFILING
John E. Schiel, Corey M. Ohnmacht, and David S. Hage*
Department of Chemistry, University of Nebraska-Lincoln, Lincoln, Nebraska 68588-0304

Abstract
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The rate at which a drug or other small solute interacts with a protein is important in
understanding the biological and pharmacokinetic behavior of these agents. One approach that has
been developed for examining these rates involves the use of high-performance affinity
chromatography (HPAC) and estimates of band-broadening through peak profiling. Previous work
with this method has been based on a comparison of the statistical moments for a retained analyte
versus non-retained species at a single, high flow rate to obtain information on stationary phase
mass transfer. In this study an alternative approach was created that allows a broad range of flow
rates to be used for examining solute-protein dissociation rates. Chromatographic theory was
employed to derive equations that could be used with this approach on a single column, as well as
with multiple columns to evaluate and correct for the impact of stagnant mobile phase mass
transfer. The interaction of L-tryptophan with human serum albumin was used as a model system
to test this method. A dissociation rate constant of 2.7 (± 0.2) s−1 was obtained by this approach at
pH 7.4 and 37°C, which was in good agreement with previous values determined by other
methods. The techniques described in this report can be applied to other biomolecular systems and
should be valuable for the determination of drug-protein dissociation rates.

INTRODUCTION
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The binding of drugs with proteins can be studied by many techniques, such as equilibrium
dialysis, microdialysis, ultrafiltration, and various chromatographic methods.1–13 The
association equilibrium constants and degree of binding that are measured using these
techniques are useful in helping to describe the transport and pharmacokinetics of drugs in
the body.14 For instance, human serum albumin (HSA) is a major serum protein in humans
that is responsible for binding and transporting numerous drugs in blood.15 It is known that
the kinetics of such an interaction can play a significant role in the distribution, half life and
activity of a given drug or hormone.16, 17
In the case of drug-protein binding in serum, it is generally assumed that the overall extent
of protein binding is important and that the resulting free, or unbound, fraction of a drug is
the biologically-active form (i.e., a model known as the “free drug hypothesis”).18,19
However, there are some cases in which the free form of a drug does not directly correlate
with its tissue uptake or bioavailability.16,17,20–28 This has led to some competing models to
describe drug delivery and uptake, such as those that incorporate receptor-mediated
transport of drugs that are bound to specific serum proteins23, 25 or those in which the rate of
a drug/protein interaction falls in a range that can contribute to deviations from the free drug
hypothesis.16, 17, 24, 27 Rate constant measurements for these interactions are needed to
*
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compare these models, to determine when the free drug fraction is important, and to better
predict the in vivo behavior that would be expected for a drug.29 In addition, measurements
of both the extent and rate of drug binding to serum proteins could be valuable in the
screening of new drug candidates and in the design of improved analytical methods for
determining the biologically-active fractions of drugs and other solutes in biological
samples.30–36
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Previous analytical techniques for examining the kinetics of drug-protein interactions have
included stopped-flow analysis,37–40 surface plasmon resonance (SPR),35 microdialysis,29
and various affinity chromatographic methods.11,41–51 Stopped-flow techniques are limited
to cases in which a suitable change in a spectroscopic signal is available to study a given
drug-protein interaction.37 SPR is commonly used in studying the kinetics of biomolecular
systems; however, it has seen only very limited use for studying the rate of drug interactions
with HSA and other serum proteins.35 It has been suggested this lack of applications for
SPR in this area is partly due to the relatively fast association/dissociation processes that are
often present in the interactions of drugs with serum proteins like HSA.29,45,51 Another
problem in the use of SPR with these systems is that it can be difficult to obtain accurate
data for weak binding by low mass drugs with limited solubility because the signal in SPR is
proportional to the analyte’s concentration, mass, and affinity for the immobilized ligand.35
The microdialysis method has recently been adapted for use in examining the kinetics of
drug-protein binding but requires HPLC for the later separation and measurement of drug in
the dialysate, which can limit the throughput of this approach. This method also requires the
careful selection of appropriate conditions for kinetic studies and makes use of non-linear
curve fitting methods.29 Past work using affinity chromatography and HPAC to examine the
kinetics of drug-protein interactions11, 41–51 and other systems of biological interest52–54 has
involved techniques based on plate height or band-broadening measurements,31–48,50–54 and
peak decay analysis.49,50 Of these two approaches, the use of plate height or bandbroadening measurements has received the most attention as a means for examining the rates
of solute-ligand interactions.41–48,50–54
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One variation on the band-broadening measurement approach is a method that has recently
been referred to as ”peak profiling”.11 The concept of peak profiling goes back to 1975,
when expressions were derived for the first and second moments for an eluting analyte peak
that could be used to calculate the dissociation rate constant for this analyte from an
immobilized ligand based on the observed profiles for both the analyte and a non-retained
species.55 This approach was first used with low-performance supports and measurements
made at a single flow rate to study the self-association of bovine neurophysin II and the
binding of this agent with the neuropeptide Arg8-vasopressin.56–58 A mathematically
equivalent approach was later used to study the rate of interaction of sugars with
immobilized concanavalin A.53 However, these methods gave values that were later thought
to be underestimated due to either the presence of significant sources of band-broadening
other than stationary phase mass transfer56–58 or the possible presence of non-linear elution
conditions (i.e., concentration-dependent behavior).53,54 The method of peak profiling was
recently examined again by using it with measurements conducted at single linear velocities
and high flow rates to increase the relative contribution of "kinetic" broadening to the
measured peak variances.11 Although the results gave reasonably good agreement with those
expected for a model system, this method did assume that there was no sample size
dependence in the measured variances and that no major contributions to bandbroadening
other than stationary phase mass transfer were present at the flow rate that was used for the
kinetic studies.11
The use of peak profiling or a related method for rapidly determining solute-protein
dissociation rate constants could be a valuable tool for determining and modeling the
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expected kinetics of these interactions for potential drug candidates.17,33,34 In this current
paper, an alternative approach based on this technique, as illustrated in Figure 1, is described
and explored for use in such studies. In this method, the analyte of interest and a nonretained solute are injected at several flow rates onto an affinity column under conditions
where retention is independent of concentration (e.g., linear elution conditions). The
observed peaks are then fit to an exponentially-modified Gaussian (EMG) model59 (e.g., a
Gaussian model with an additional exponential decay function) to give the first and second
moments for the analyte and nonretained solute peaks. An equation derived from
chromatographic theory is described and used to analyze these results through linear
regression. Equations will also be developed to determine the effects of stationary phase
mass transfer in such measurements when the experiment is performed on multiple columns.
This approach is tested and evaluated by using the binding of L-tryptophan with HSA as a
model system, making it possible to compare the results of this work with those obtained
through previously-described techniques based on peak profiling or plate height
measurements.11, 51 The method presented in this report is a general one that should be
useful in examining a variety of other biological interactions, including drug-protein
binding.

THEORY
General Model
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The binding of a drug or small solute with a protein like HSA is often described by the
following reversible interaction.3
(1)

(2)
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The association equilibrium constant (Ka) for this system is given in eq 2 by the ratio of the
second-order association rate constant (ka) and the first-order dissociation rate constant (kd).
Peak profiling and band-broadening methods seek to determine kinetic values for a system
like the one in eq 1 by passing a small plug of solute A through a column that contains an
immobilized form of protein or ligand P. The first and second statistical moments for the
resulting sample peak are measured and used to describe the retention and band-broadening
of A, respectively. The second moment is then related to the kinetics of the interaction
between A and P, after correcting for other sources of band-broadening in the column.50
The contributions to band-broadening that can occur as A passes through a column
containing P include mobile phase mass transfer and eddy diffusion (as described
collectively by the plate height term Hm), longitudinal diffusion (Hl), stagnant mobile phase
mass transfer (Hsm), and stationary phase mass transfer (Hk).50 These plate height terms are
commonly viewed as being additive in nature and together make up the total observed plate
height, Htot. It is expected from these terms that varying the flow rate or linear velocity for a
given separation will affect the retention and broadening of an eluting peak, as shown in
Figure 2. When peak profiling is performed at a single flow rate, it has been suggested that it
is desirable to increase the flow rate to obtain a condition in which the “kinetic” contribution
to the band-broadening dominates (i.e., stationary phase mass transfer is a major component
of band-broadening).11 Under such conditions, it has been further suggested that eq 3 can be
used to calculate kd,
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where tR and σR2 are the retention time and variance of the peak for the injected analyte
(with σR being the corresponding standard deviation), while tM and σM2 are the void time
and variance of the peak (with a standard deviation of σM) for a non-retained solute under
equivalent column and flow rate conditions.11, 55 One assumption made in eq 3 is that all
band-broadening contributions other than stationary phase mass transfer are the same for the
retained and non-retained solutes. The effect of deviations from this assumption will be
discussed later in this section.
Peak Profiling at a Single Flow Rate
In recent work using peak profiling at a single flow rate (or single linear velocity), two terms
were used to identify an appropriate flow rate at which dissociation kinetics could be
determined for a given solute-protein interaction. The first of these two terms was the
critical ratio (η), as defined by eq 4.11
(4)

NIH-PA Author Manuscript

It can be shown that this ratio can also be written as given in eq 5,
(5)

where HR is the total plate height measured for a retained solute and HM is the total plate
height measured under the same conditions for a non-related solute. In a previous paper it
has been suggested that peak profiling at a single flow rate should be performed under
conditions in which the value of η is greater than one.11 It can be seen from eq 5 that this
situation occurs when HR > HM and that η continues to increase as the difference in total
plate height becomes larger for the retained versus non-retained solute.
To account for the dependence of plate height on linear velocity or flow rate, workers in
Ref. 11 also derived a term called the “kinetic factor” (κ), which was defined as shown in eq
6.11
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(6)

If eq 5 is inserted into this expression, the result is the following alternative form of eq 6.
(7)

If it is assumed that the only difference between HR and HM is due to stationary phase mass
transfer, eq 7 indicates that κ is a measure of the total band-broadening of the retained peak,
as represented by σR2, versus the fraction of band-broadening that is not due to Hk, as given
by (HM/HR) · σR2. It has been suggested in Ref. 11 that the value of κ should eventually
level off as the linear velocity or flow rate is increased, thus indicating the conditions at
which the kinetic contribution to band-broadening is maximized. Band-broadening
measurements that are obtained at such a flow rate are then used along with eq 3 to

Anal Chem. Author manuscript; available in PMC 2012 September 17.

Schiel et al.

Page 5

NIH-PA Author Manuscript

estimated kd.11 A dissociation rate constant that is estimated by this approach and that uses
peak profiling at a single flow rate will be represented by the term "kd,s" throughout the
remainder of this current report.
Peak Profiling at Multiple Flow Rates
It is possible to rearrange eq 3 into the following form and to use data from multiple flow
rates to determine kd (see Supporting Information for derivation).
(8)

NIH-PA Author Manuscript

It is interesting to note that the difference (HR − HM) in eq 8 is simply equal to the plate
height contribution due to stationary phase mass transfer (Hk). Eq 8 can also be derived by
using other methods when the same assumption is made.53,60,61 This equation shows the
link between peak profiling and the plate height method, in that peak profiling can now be
seen to be a special subset of the latter. In addition, this equation demonstrates that peak
profiling at a single flow rate, as represented by eq 3, assumes that HM and HR only differ in
terms of their value for Hk, which contributes to HR but not HM. This assumption does not
require that HM is constant (e.g., this term would be expected to vary with flow rate
according to the van Deemter equation or related expressions), but it does require that the
value of HM be the same under any given set of experimental conditions for both the
retained and non-retained solutes that are being injected.
Eq 8 predicts that a plot of (HR − HM) versus the term (u k)/(1+k)2 should result in a linear
relationship with a slope equal to 2/kd. It will be shown later in this report how such a plot
can be used to determine a dissociation rate constant for an analyte-ligand interaction based
on data obtained at multiple flow rates, thereby increasing the accuracy and precision of the
estimated kd value. Dissociation rate constants that are determined through this multiple
flow rate approach and by using a linear plot will be referred to in this discussion by using
the term "kd,l".
Effects due to Stagnant Mobile Phase Mass Transfer & Diffusion
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It was indicated earlier that one simplifying assumption made in both eqs 3 and 8 is that the
retained and nonretained species have all the same band-broadening contributions to their
total measured plate height except for the contribution due to stationary phase mass transfer
(Hk). However, the plate height contribution due to stagnant mobile phase mass transfer for
a retained and a non-retained species may not be identical for these two solutes due the
dependence of this band-broadening process on the retention factor k.50 It is possible to
account for this effect in the use of multiple flow rates for peak profiling method by
expanding eq 8 into the form shown in eq 9 (see derivation in Appendix).
(9)

In this equation, γ is the tortuosity factor, D is the diffusion coefficient for the analyte or
non-retained solute in the bulk mobile phase, and dp is the particle diameter of the support
material. Eq 9 is similar in form to eq 8 in that it predicts that a linear relationship will exist
between (HR − HM) and (u k)/(1+k)2; however, the slope of this plot now depends on two
general terms, as given in eq 10. The first of these two terms (2/kd) represents the
contribution to the slope due to stationary phase mass transfer. The second term represents
the contribution to the slope due to stagnant mobile phase mass transfer.
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Eq 10 predicts that the contribution from stagnant mobile phase mass transfer will cause the
measured slope m to vary with the particle diameter (dp) of the support material in the
column. This observation makes it possible to correct for the effect of stagnant mobile phase
mass transfer on this measured slope by performing peak profiling on multiple columns that
contain packing materials with different but known particle sizes. If the slope from eq 9 is
determined for several such columns, a plot of this slope can be made versus dp2, which is
predicted by eq 10 to give an intercept that provides the true value for the dissociation rate
constant, kd. An alternative approach that can be used when comparing columns with
significantly different activities and values for k is to plot the slope m versus the term dp2
(2+3 k), which also gives an intercept that can be used to obtain kd.
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It should be noted at this point that the derivation of eq 10 does assume that the ratio of the
void volume and pore volume in the column is approximately equal to two (i.e., VM/VP =
2), which is a typical value for porous silica particles50 and for the specific materials
employed in this study (note: this value is also essentially the same for porous silica with
different particle sizes, as used in this report). However, if this is not the correct value for
this ratio, it will affect only the slope that is obtained for a plot of m versus dp2 and not the
intercept. As a result, changes in the value of this ratio will not affect the final value for kd
that is obtained.

EXPERIMENTAL
Reagents
The L-tryptophan (>99.5% pure) was obtained from Fluka (Seelze, Germany) and the HSA
(essentially fatty acid free, >96%) was from Sigma (St. Louis, MO). The Nucleosil Si-300
(5, 7 or 10 µm particle diameter, 300 Å pore size) was from Machery-Nagel (Duren,
Germany). Reagents for the bicinchoninic acid (BCA) protein assay were from Pierce
(Rockford, IL). All other chemicals were reagent-grade or better. All aqueous solutions were
prepared with water obtained from a Nanopure water system (Barnstead, Dubuque, IA).
Apparatus
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The chromatographic system consisted of a SPD-10AV UV/Vis detector and a LC-10AD
pump controlled by an SCL-10A system controller from Shimadzu (Columbia, MD).
Samples were injected using a SpectraSystem AS3000 Autosampler (Thermoseparations,
Waltham, MA) equipped with a 5 µl sample loop. The columns were maintained at a
constant temperature of 37.0 (± 0.1)°C using a water jacket from Alltech (Deerfield, IL) and
a Fisher Scientific 9100 circulating water bath (Westbury, NY). Chromatograms were
acquired using programs written in LabView 5.0 (National Instruments, Austin, TX). The
statistical moments of the chromatographic peaks were determined using PeakFit 4.12
(Systat Software, San Jose, CA), in which moment analysis was performed using an EMG
fit with a linear progressive baseline. The residual option in PeakFit was used to determine
the best fit for the chromatographic peaks.
Column Preparation
Three sets of columns (each set containing one immobilized HSA column and one control
column) were prepared using the 5, 7, or 10 µm particle size silica. To make these columns,
the silica was first converted to a diol form.62 The diol content of these supports was
Anal Chem. Author manuscript; available in PMC 2012 September 17.
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determined in triplicate to be 300 (± 50), 231 (± 16), and 280 (± 19) µmol diol (± 1 S.D.) per
gram of silica, respectively, as measured using an iodometric capillary electrophoresis
assay.63 Each type of silica was then split into two portions, with one portion being used to
immobilize HSA and the other portion being taken through all of the same reaction steps but
with no HSA being added during the immobilization step. The immobilized HSA support
and corresponding control support were both prepared by the Schiff base method, as
described previously.7
The protein content of each HSA support was determined in triplicate by a BCA protein
assay,64 using HSA as the standard and the control support as the blank. The measured
protein content was 68 (± 4), 57 (± 3), and 63 (± 4) mg HSA per gram of silica for the 5, 7,
and 10 µm HSA silica supports; the effective concentration of HSA (i.e., moles protein/void
volume) in the columns prepared with these supports were 540 (± 30), 450 (± 20), and 500
(± 30) µM, respectively. Each type of HSA support or control support was downward slurrypacked at 24 MPa (3500 psi) into a separate stainless steel column (5 cm × 4.6 mm i.d.)
using pH 7.4, 0.067 M potassium phosphate buffer as the packing solution All columns were
stored at 4°C in pH 7.4, 0.067 M potassium phosphate buffer when not in use.
Chromatographic Experiments
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All chromatographic studies were carried out at 37.0°C and in pH 7.4, 0.067 M potassium
phosphate buffer as the mobile phase in order to mimic physiological conditions. All
samples containing L-tryptophan or sodium nitrate (used as a non-retained solute) were
prepared in this mobile phase (note: injections of 25 µM L-tryptophan on the control column
were also explored for use in measurements of HM). The solutions of L-tryptophan were
prepared fresh each day to avoid any effects due to the slow degradation of this analyte in an
aqueous solution.65–67
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The elution of L-tryptophan was monitored at 220 nm and the elution of sodium nitrate was
monitored at 205 nm. All experiments were performed within five months of column
preparation and each column was used for less than 150 injections. Injections of 25 µM Ltryptophan and 25 µM sodium nitrate were made at 1 mL/min at regular intervals over the
course of these experiments to monitor the activity and efficiency of the columns. This
procedure was used to ensure the column had a consistent binding activity (as monitored by
measuring k) and that the efficiency of the column did not change over time (as determined
by monitoring the peak variances and plate heights). The second of these two measurements
also helped to ensure that settling of the packing material or loss of support to form a small
void space in the column had not occurred, a phenomenon which was found in preliminary
studies to significantly increase HM and lead to an overestimation of kd or, in extreme cases,
even negative kd values The retention factors for L-tryptophan displayed a relative change
between 2.2 to 12.6% for the various columns, indicating that the immobilized HSA had no
appreciable changes in its binding to L-tryptophan during the course of these experiments.
The measured plate heights for L-tryptophan, as determined from the same injections,
changed by 0.4 to 2.3% over the given time period, while the plate heights measured for
sodium nitrate changed by 9.6 to 13.8%. These latter results indicated that the efficiency of
the columns were also consistent over the course of these experiments.
Injections were made in triplicate on the HSA or control column under each set of tested
conditions. Identical injections were also made using a zero volume spacer/union in place of
the column to correct for any additional elution times or band-broadening that was created
by extra-column components of the chromatographic system. The analyte solutions that
were used to examine the effect of sample concentration during the initial linear elution
studies ranged from 5 to 250 µM for both L-tryptophan and sodium nitrate, which were
injected at 1 mL/min to represent typical measurements of HR or HM, respectively. Most of
Anal Chem. Author manuscript; available in PMC 2012 September 17.
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the later experiments used samples that contained 25 µM L-tryptophan or 25 µM sodium
nitrate that were injected at flow rates of 1 to 3.5 mL/min. This entire range of flow rates
was used to determine dissociation rate constants by using multiple flow rates and peak
profiling method. The results obtained at 3.5 mL/min were used for comparison with the
single flow rate approach that has been used in previous studies.11
Sample concentration effects in the single flow rate approach were examined by injecting 15
to 100 µM L-tryptophan or sodium nitrate onto the 7 µm particle size HSA column at 3.5
mL/min. Sample concentration effects in the multiple flow rate peak profiling method were
studied using injections of 40 µM L-tryptophan on the 7 µm particle size HSA column at
flow rates ranging from 1 to 3.5 mL/min. In all of these studies, a sample containing 25 µM
sodium nitrate injected onto the same HSA column and was used as a non-retained void
marker. Sample concentration effects were also studied on the 5 µm particle size HSA
column.

RESULTS AND DISCUSSION
Selection of Analyte & Conditions for Peak Profiling at a Single Flow Rate
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L-Tryptophan was employed throughout this study as a model solute to test and compare
various methods for dissociation rate constant measurements. This solute is known to bind
specifically to HSA at the indole-benzodiazepine site, or Sudlow site II,14 and is commonly
used in competition studies to determine if other solutes or drugs also bind to at this
site.1, 2, 6 The rate constants and equilibrium constants for this interaction have been
previously characterized at various pH values and temperatures by using equilibrium
dialysis8 and affinity chromatography.11,51,68,69 Under the conditions used in this study (pH
7.4 and 37°C), an association equilibrium constant of 1.1 × 104 M−1 has been reported for
the binding of L-tryptophan with HSA;3 and the dissociation rate constant has been
estimated to be 3–6 s−1, with the latter being determined by the plate height method and
peak profiling at a single flow rate11, 51 (i.e., the two approaches used as reference methods
in this current report). All of these features made the L-tryptophan/HSA system a valuable
tool for evaluation of the approaches described in this report for measuring drug-protein
dissociation rates by HPAC.
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The conditions used in this report with peak profiling method at a single flow rate were
chosen to allow a direct comparison to be made with results reported in Ref. 11 for the Ltryptophan/HSA system. These conditions involved the use of a 5 cm × 4.6 mm i.d. HSA
column containing silica particles with a pore size of 300 Å and an average diameter of 7
µm, with this column being operated at flow rates up to 3.5 mL/min. Additional studies were
conducted to examine the effects of varying the support’s particle diameter and the flow rate
on the results obtained with peak profiling at a single flow rate. This work was initially
carried out with a sample containing 25 µm L-tryptophan to provide linear elution behavior
as well as a sufficient peak size for reliable retention time and variance measurements.
However, the effect of working at other sample concentrations (e.g, the 100 µm Ltryptophan samples used in Ref. 11) was also considered (see next section).
Experiments performed early in this report examined the effect flow rate had on the
measured variances and plate heights for L-tryptophan on HSA columns. Figure 3(a) shows
typical plots of plate height versus linear velocity that were obtained for L-tryptophan and
sodium nitrate (i.e., a non-retained solute) on an HSA column containing a 300 Å pore size,
7 µm particle size support. The linear velocities in this plot are equivalent to flow rates of
1.0 to 3.5 mL/min on the given column. The resulting plate height curves shown in Figure
3(a) agree with observations made in past band-broadening studies for L-tryptophan on
similar HSA columns.51,70 It was determined from these curves that the linear velocities
Anal Chem. Author manuscript; available in PMC 2012 September 17.
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used in this study were at or above the minimum plate height in this van Deemter-type plot,
as occurred at about 0.1 to 0.15 cm/s. Past work with the peak profiling method at a single
flow rate sought to use high flow rates for dissociation rate constant measurements to reduce
the effects of “non-kinetic” contributions in these experiments.11 It can be seen from Figure
3(a) that the use of a lower flow rate in this approach would suffer from both a loss of
accuracy (as other contributions to band-broadening become more important) and from a
decrease in precision (as smaller differences occur between the band-broadening observed
for the retained versus non-retained species. Thus, the selection of a suitably fast flow and
linear velocity is critical in this particular technique.
Use of Peak Profiling at a Single Flow Rate
The data in Figure 3 were first examined by using eq 3 and peak profiling method at a single
flow rate. It has been suggested previously by others that such a measurement should be
made when the term η2 is greater than one, as calculated by using eq 4 or 5. Such a situation
occurred in Figure 3(a) when the linear velocity was greater than approximately 0.15. It has
also been stated previously that accurate values for kd in this method can only be determined
when using a flow rate that is sufficiently high to cause the term κ (as given by eq 6 or 7) to
approach a constant value.11 In this particular study the value of κ was found to increase
with linear velocity but did not reach a constant value over the range of flow rates that were
tested, including the upper flow rate limit of 3.5 mL/min, as illustrated in Figure 3(b).
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Figure 3(c) shows how the apparent dissociation rate constant measured by peak profiling at
a single flow rate (kd,s) changed with linear velocity for L-tryptophan injected onto the given
HSA column. The data obtained at the three highest linear velocities in this plot
(corresponding to flow rates of 2.5, 3 and 3.5 mL/min) gave kd,s values of 6.4 (± 0.1), 4.0 (±
0.2), and 3.1 (± 0.1) s−1, respectively. Although these kd,s approached a limiting value at
high linear velocities, there were significant differences between the estimated dissociation
rate constants even the highest linear velocities tested in Figure 3(c). Using a lower linear
velocity resulted in an increase in kd,s as the value of HR grew closer to HM. At the lowest
linear velocity that was sampled, the measured value for HR was even slightly less than HM
(although statistically equivalent), which created an apparent value for kd,s that was
negative. These observations all confirmed the need to use high linear velocities to obtain
reasonable and consistent values for dissociation rate constants when using peak profiling at
a single flow rate.
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It is interesting that although the dissociation rate constants in Figure 3 and Ref. 11 were
obtained using the same method, type of analyte, protein, column dimensions, support
particle diameter, and mobile phase, there were notable differences in the final results. The
best agreement was obtained between the kd,s value of 6.4 (± 0.1) determined in Figure 3 at
2.5 mL/min and the “kinetic limited” value of 6.9 (± 0.03) reported in Ref. 11 at 3.5 mL/
min. In addition, the kd,s found in this current study for L-tryptophan and HSA appeared to
approach a value below 3 s−1 as the flow rate was increased to 3.5 mL/min. These
differences may be due to the use of different immobilization methods, protein contents or
packing efficiencies for the HSA supports used in these two studies. For example, the
column in Ref. 11 had an effective concentration for active immobilized HSA of 181 µm,
while the HSA columns in this current study had total concentrations between 450 to 540
µm and active concentrations were conservatively estimated to be in range of 225 to 300
µm.7 Regardless of the cause of the difference, these results do indicate that column-tocolumn variability can affect the optimum flow rate conditions and apparent dissociation
rate constants that are obtained when using peak profiling at a single flow rate. If this factor
is not considered, it can result in a systematic error in the final value of kd,s if a sufficiently
high flow rate is not selected for such a measurement. This effect represents another
limitation of using only a single flow rate in the peak profiling method.
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The effect of the support material in the single flow rate, peak profiling method was
examined more closely by preparing HSA columns that contained silica with particle sizes
of 5, 7 or 10 µm particles and a pore size of 300 Å. These supports were all prepared by the
same immobilization technique and had similar protein content (see Materials and Methods).
However, the efficiency of these columns was different because they contained different
diameter particles, a factor that affects stagnant mobile phase mass transfer and mobile
phase mass transfer/eddy diffusion. HSA columns containing these supports gave the same
general behavior for plate height curves and plots of κ versus linear velocity as shown in
Figure 3 for HSA columns containing 7 µm silica particles. However, the apparent
dissociation rate constants measured with these columns did differ when the same flow rate
was used for these studies. Table 1 shows the results obtained when working at a flow rate
of 3.5 mL/min (i.e., the highest flow rate used in Figure 3). The smallest diameter and most
efficient support (5 µm particle size) gave the largest estimate of the dissociation rate
constant (4.1 s−1), with a two-fold decrease in kd,s being found as the particle size was
increased to 10 µm.
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This last set of results indicated that the efficiency and diameter of the support material can
have a significant effect on the apparent dissociation rate constant that is measured when
using peak profiling at a single flow rate. The change seen in kd,s with particle size also
indicates that the difference between the plate height of the retained and non-retained
species in this approach is not necessarily equal to only the plate height contribution due to
stationary phase mass transfer, as is assumed in eqs 3 and 8. Instead, these results suggest
that this difference also reflects contributions due to other band-broadening processes that
are affected by the particle diameter of the support, such as the stagnant mobile phase mass
transfer and mobile phase mass transfer/eddy diffusion.
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The sample concentration dependence of peak profiling at a single flow rate was also
assessed. This was examined by injecting at 3.5 mL/min various concentrations of sodium
nitrate and L-tryptophan on an HSA column containing 7 µm diameter silica particles. It was
found that HM remained approximately constant once a sufficiently high concentration of
sodium nitrate was injected (e.g., 25 µM), which allowed peaks for this solute to be of a
sufficient size for accurate determination of its statistical moments. The value of HR,
however, showed a continual increase as the sample concentration of L-tryptophan was
raised, indicating that some non-linear elution effects were present. The result was a slight
decrease in kd,s with an increasing sample concentration of L-tryptophan, as shown in Figure
4 (Note: these studies were all conducted using 25 µM sodium nitrate as the non-retained
solute). The value of kd,s changed from 3.6 (± 0.7) to 2.74 (± 0.03) s−1 at 3.5 mL/min when
going from sample concentrations that ranged from 10 to 100 µM L-tryptophan (i.e.,
samples representing 0.011 to 0.11% of the estimated HSA column loading capacity), with
the latter concentration being the value used in Ref. 11. The value of kd,s measured for 25
µM L-tryptophan (i.e., 0.03% of the HSA column loading capacity and the sample used
throughout most of this current study) was 3.2 (± 0.2) s−1 at 3.5 mL/min. These results
indicated that there can be a concentration dependence for kd,s when using peak profiling at
a single flow rate. However, the effect in this case was relatively small compared to the
changes noted in kd,s when varying the flow rate or particle diameter.
Selection of Conditions for Peak Profiling at Multiple Flow Rates
The limitations noted in the last section for peak profiling at a single flow rate indicated that
an alternative and more robust technique was needed for dissociation rate constant
measurements. An alternative technique that could be used over a broader range of flow
rates is the plate height method. However, this approach can also present difficulties if there
are only small changes in the band-broadening of the non-retained species as a function of
flow rate. This problem can be illustrated with the plate height data for sodium nitrate in
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Figure 3(a), for which a quite small slope was obtained. This small slope results in a large
uncertainty in the final estimate of Hsm and in the final determined value of kd. In some
cases, the slope of the plate height curve for the nonretained species may even have a
slightly negative value but one that is statistically equivalent to zero; this results in an
apparent negative value of kd if error propagation is not correctly considered. Both of these
effects indicate the need for a more direct measure of kd, as was considered in this report
through the use of peak profiling at multiple flow rates.
Peak profiling at multiple flow rates, which can be viewed as an extension and modified
version of the plate height method, was conducted in this study by using the same columns
and support particles as used for peak profiling at a single flow rate in the previous section.
The entire flow rate range considered in the single flow rate approach was also used for this
work (i.e., 1.0 to 3.5 mL/min). As shown by the plate height curves to the left in Figure 5,
this flow rate range extended from the minimum region of the plate height plots (i.e., where
HR and HM had approximately the same value) to the linear region of these plots (where HR
became much greater than HM). In addition, the upper flow rate of 3.5 mL/min made it
possible to compare the methods examined in this study with those used in a previous
report11 while still providing a reasonable back pressure for these experiments (e.g., 7.0
MPa or 1030 psi at 3.5 mL/min on the HSA column containing 5 µm support particles).
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The effect of varying the sample concentration of the analyte was again considered. In this
case it was desired to not only have linear elution conditions but also to obtain consistent,
positive values for (HR − HM). An example of such an experiment is shown in Figure 6 for
injections of various concentrations of L-tryptophan at 1 mL/min onto an HSA column
containing 5 µm support particles; a fixed concentration of 25 µM was used for sodium
nitrate as the non-retained solute, as found to be optimum in the previous section. This
specific column was chosen for this study since it had the smallest diameter support and was
the most efficient of the three columns used in this work. This column would be expected to
give the smallest difference in plate height between the retained and non-retained species,
making it easier to see any variations in (HR − HM) due to a change in sample concentration.
In addition, the flow rate of 1 mL/min was at or near the minimum region of the plate height
plots, also creating a situation in which any variations in (HR − HM) would be easier to
detect and monitor.
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The results in Figure 6 indicate that the value of (HR − HM) increased as the concentration
of L-tryptophan was raised. Concentrations up to 25 µM L-tryptophan gave (HR − HM)
values that agreed within ± 1 S.D. However, larger sample concentrations gave large
increases in (HR − HM) and lead to significant deviations from the results obtained when
using L-tryptophan concentrations at or below 25 µM. Based on these results, a sample
concentration of 25 µM L-tryptophan was used in all later peak profiling experiments. The
effect of using higher sample concentrations on the apparent dissociation rate constant that is
measured by using peak profiling at multiple flow rates will be examined in the next section.
General Results for Peak Profiling at Multiple Flow Rates
The use of eq 8 for conducting peak profiling at multiple flow rates was next considered.
This work was carried out using the same data, samples and columns as employed in the
previous work with peak profiling method at a single flow rate (i.e., 25 µM L-tryptophan or
25 µM sodium nitrate and flow rates that ranged from 1.0 to 3.5 mL/min). The right hand
side of Figure 5 shows the resulting plots of (HR − HM) versus (u k)/(1+k)2 that were
obtained for HSA columns that were prepared with support particles that were 5, 7 or 10 µm
in diameter.
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Good agreement with a linear response was generally observed for the plots of (HR − HM)
versus (u k)/(1+k)2. Correlations of 0.966 to 0.983 (n = 7) were obtained for these plots over
the entire flow rate range that was studied. This response was in agreement with the linear
behavior that was predicted for such a plot by eq 8. The slopes of these plots were then used
along with eq 8 to estimate the dissociation rate constant for the L-tryptophan/HSA
interaction on each of the columns. The rate constants that were obtained are listed in Table
1. The three types of supports that were tested gave slightly different values for the apparent
dissociation rate constant (ranging from 1.5 to 2.2 s−1). These differences were later found
to be a result of the different particle sizes of the supports in these columns and the resulting
differences in stagnant mobile phase mass transfer, as will be discussed in the next section.
However, it should also be noted that the difference in these values was much less than that
found when using single linear velocities for peak profiling (1.9 to 4.1 s−1 at 3.5 mL/min), a
method which was also subject to changes in stagnant mobile phase mass transfer. A lower
degree of variability in dissociation rate constant measurements was expected when using
multiple flow rates for peak profiling because such an approach would tend to average out
variations that would be obtained when using individual flow rates or columns. In addition,
the multiple flow rate method appears to correct for some retention-dependent contributions
to peak profiling that are seen when using a single flow rate, as described below.
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The change in the apparent dissociation rate constant (kd,l) that was obtained when
comparing the plots of (HR − HM) versus (u k)/(1+k)2 in Figure 5 was a result of the slightly
different slopes for these plots. This variation in the slope was caused by differences in the
relative contribution of stagnant mobile phase mass transfer to the results for each type of
support, as predicted by eq 9 and as discussed in the next section. However, there were some
other changes in these plots that were related to the slight differences in retention for Ltryptophan on the individual HSA columns and which did not affect the measured slopes.
These latter changes were produced by a small decrease in the retention factor in going from
the HSA column with a 5 µm diameter support to the columns that contained 7 µm or 10 µm
diameter supports (i.e., k = 13.8 (± 0.1), 12.95 (± 0.02), 12.38 (± 0.02) at 1 mL/min,
respectively, with similar trends being seen at other flow rates). A lower value for k resulted
in a larger value for (u k)/(1+k)2, which caused a net shift to the right on the x-axis in a plot
of (HR − HM) versus (u k)/(1+k)2 when using columns that contained an increasing support
particle diameter. This slight change in retention is also believed to have contributed to a
small shift in the y-axis for plots of (HR − HM) versus (u k)/(1+k)2 in Figure 5. Similar
changes in (HR − HM) with retention have been noted in previous work with HSA
columns.45 This second effect is believed to be due to changes in the plate height due to
mobile phase mass transfer (Hm) with a change in the retention factor,45 a phenomenon that
has been suggested by others in work with chromatographic theory.71,72 This dependence
would affect the values of HR and HM differently, thus creating a constant shift in the (HR −
HM) values on the y-axis. This shift was most evident for the column containing the 10 µm
support particles, as would be expected since the relative size of Hm is proportional to
particle size.
Because these retention-based effects tended to produce a net shift for all data points that
was constant for a given type of support, they did not affect the slopes measured for the
plots (HR − HM) versus (u k)/(1+k)2 or the dissociation rate constants that were determined
from these slopes. However, this retention dependence and resulting shift would be expected
to affect the results of peak profiling at a single flow rate, in which Hm is assumed to be
negligible or constant for the non-retained versus retained solutes and no corrections are
made for changes in k as a result of differing column activities. When using peak profiling at
a single flow rate, a shift in the value of (HR − HM) and/or (u k)/(1+k)2 due to a change in
retention would have contributed to the greater variability of this latter approach when
comparing data obtained with different columns. This same type of shift would also explain
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the tendency of the single flow rate, peak profiling method to give larger apparent
dissociation rate constants when compared to the use of multiple flow rates for peak
profiling.
The effect of a small increase in sample concentration on the results when using multiple
flow rates for peak profiling was next examined. In this case, the concentration of Ltryptophan was raised from 25 µM to 40 µM and injected the HSA column containing a 7
µm diameter support. The flow range that was tested was the same as that shown in Figure 5
and 25 µM sodium nitrate was again injected as the non-retained solute. The resulting graph
of (HR − HM) versus (u k)/(1+k)2 (data not shown) had greater curvature than the
corresponding plot in Figure 5(b) (which also had a small amount of curvature) and a lower
correlation coefficient of 0.929 (n = 7) for the best-fit line. Although this increased curvature
resulted in a less precise estimate of the dissociation rate constant when using the 40 µM Ltryptophan sample, the value of 2.0 (± 0.4) s−1 that was obtained was still statistically
equivalent to that found for a 25 µM sample (see Table 1). These data indicated that the use
of multiple flow rates for peak profiling can provide robust dissociation rate constant
measurements that are insensitive to small variations in sample concentration.
Effect of Differences in Stagnant Mobile Phase Mass Transfer
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Although the use of multiple flow rates was found to increase the precision and decrease the
inter-column variation in estimates of dissociation rate constants, both this method and the
single flow rate approach may still give an apparent value of kd that is affected by stagnant
mobile phase mass transfer. The size of this effect was examined in this report by looking at
how the slope of a plot of (HR − HM) versus (u k)/(1+k)2 (used to determine the apparent kd)
changed when this slope is plotted as a function of dp2, where dp is the particle diameter of
the support. According to eq 10, this second type of plot should produce a linear relationship
in which the intercept gives the true value for the dissociation rate constant between the
analyte and immobilized ligand. Figure 7 shows the graph that was actually obtained for the
various support diameters used in this report. Although only three support diameters were
examined in this particular case, these conditions did span over a 4-fold range in values for
dp2 and appeared to give good agreement with the linear trend predicted by eq 10 over this
range.
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The intercept of Figure 7 gave a dissociation rate constant of 2.7 (± 0.2) s−1 for the Ltryptophan system, which was now corrected for any contributions due to stagnant mobile
phase mass transfer. This result fell within the range of 1.9 – 6.9 s−1 that was obtained
earlier in this current study and in Ref. 11 for this dissociation rate constant when using peak
profiling at a single flow rate. In addition, this result agreed with data obtained in previous
band-broadening measurements, which gave estimated dissociation rate constants at pH 7.4
of 4 (± 1) s−1 at 25°C or 5.5 (± 1) s−1 at 37°C.45, 68
The same data as used in Figure 7 were examined by preparing a plot of the measured slope
versus dp2 (2+3 k). According to eq 10, such a plot would again allow the dissociation rate
constant to obtained from the intercept while also correcting for the small differences in
retention that were noted earlier for L-tryptophan on the various HSA columns that were
used in these studies. This new plot was again found to be linear, with a correlation
coefficient of 0.994 (n = 3). The intercept of this plot provided a value for kd of 2.8 (± 0.2)
s−1, which was within 1 S.D. of the value obtained from Figure 7. The similarity of these
values indicated that the small changes in retention noted for the various HSA columns did
not lead to any appreciable errors in the value of kd given by Figure 7. This result was
expected in this particular case because the four-fold increase for dp2 in Figure 7 was much
larger than the maximum column-to-column variation of 10–11% in k that was measured for
the specific HSA columns that were used to obtain this plot. However, if this approach is to
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be used with a system that exhibits a larger change in k between columns, it would be
preferable to use eq 10 along with a plot of the measured slope versus dp2 (2+3 k) instead of
the slope versus dp2 to minimize the effects of these differences in retention.
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Several interesting observations can be made when comparing the final estimated kd of 2.7
s−1 with the individual values that were obtained when using single or multiple flow rates
for peak profiling. For instance, it was found that using peak profiling at a single flow rate
did give a useful preliminary estimate for kd in this case, but with a relatively large amount
of variability being seen in the results of this approach depending on the particular
experimental conditions that were used for this measurement (e.g., flow rate, sample size,
and type of column, as noted in this report). A much smaller degree of variability was noted
when using peak profiling at multiple flow rates. However, as expected from eq 10, the final
value found for kd after correcting for stagnant mobile phase mass transfer was always
higher than the apparent values that were obtained when using peak profiling at multiple
flow rates if no correction was made for stagnant mobile phase mass transfer. The column
with the smallest diameter support (5 µm particles, in this case), gave the closest estimate of
kd in multiple flow rate studies compared to the extrapolated value from Figure 7, with an
error of only 18%. The other columns gave errors versus the extrapolated value for kd of
26% and 44% for the 7 µm and 10 µm diameter supports, respectively, when using multiple
flow rates with peak profiling. The use of affinity supports with even smaller diameters or
smaller contributions to stagnant mobile phase mass transfer (e.g., non-porous or monolithic
media)74–76 would be expected to give even closer agreement in the apparent and actual
values for kd in such an experiment; such materials might be used in future work to
minimize these errors and avoid the need for using multiple columns in these studies.
The fit of the data in Figure 7 was further examined by using the slope that was obtained for
the best-fit response. According to eq 10, this slope is related to the retention factor for the
solute (k, a known parameter) and the product γ D, where γ is the tortuosity factor for the
solute as it moves within the support particles and D is the solute’s diffusion coefficient in
the bulk mobile phase. If the tortuosity factor is assumed to be in the range of 0.1 to 0.5,50
the resulting diffusion coefficient would be in the range of 12.0 (± 1) × 10−6 to 2.4 × 10−6 (±
0.2) cm2/s, respectively. These diffusion coefficients are in a reasonable range for a small
solute such as L-tryptophan 71 again indicating that there is good agreement between the
response that is predicted by eq 10 and the experimental results noted in this study.
Effect of Changes in Stagnant Mobile Phase Mass Transfer
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One assumption made in the derivation of both eqs 9 and 10 (as well as eqs 3 and 8) is that
the rate of stagnant mobile phase mass transfer is the same for the non-retained species and
the retained analyte. This assumption requires that the product γ · D in eqs 9 and 10 be the
same for these two species. However, an expanded form of eq 10 can be obtained that does
not make this assumption, as shown below in eq 11 (see Appendix).
(11)

This expanded equation uses two separate stagnant mobile phase mass transfer terms, as
shown in parentheses to the right of eq 11. For the sake of simplicity, the difference in these
two terms is represented by a difference in their diffusion coefficients for the retained and
non-retained species, as represented by DR and DM, respectively. However, the above
relationship could also be written in a form that allows both the tortuosity factor and
diffusion coefficient to vary between the retained and non-retained species by using the
combined terms (γ · D)R and (γ · D)M instead of γ · DR and γ · DM in eq 1.
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According to eq 11, a plot of the measured slope m versus dp2 for a peak profiling study will
again give a linear plot. The slope of this plot will be affected by a difference in stagnant
mobile phase mass transfer between the retained and non-retained solute, but the intercept of
this plot will still be equal to 2/kd. Thus, eq 11 indicates the approximation made in eq 10
that the rate of stagnant mobile phase mass transfer is the same for the retained and nonretained solutes will not affect the final value for kd that is determined when using peak
profiling at multiple flow rates and with multiple columns that have supports with different
particle sizes.
It is possible, however, that a change in the rate of stagnant mobile phase mass transfer
between the retained and non-retained species could lead to differences in dissociation rate
constants that are estimated using individual columns. To determine the size of this effect,
peak profiling studies on a single type of column were conducted using two independent
measures of HM: one set using sodium nitrate injected onto an HSA column (as used
previously throughout this report), and second set using injections of L-tryptophan on an
inert control column (i.e., based on injections of 25 µM L-tryptophan). These values were
compared using data for the HSA and control columns that contained 7 µm support particles.
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The results obtained when using sodium nitrate on the HSA column to measure HM were
given earlier in Figure 3. A similar plot was obtained over the same range of flow rates
when using injections of L-tryptophan on the control column to estimate HM (data not
shown; correlation coefficient = 0.981, n = 7). The slope of this second plot gave an
estimated value for kd,l of 1.7 (± 0.2) s−1. This result was within one standard deviation of
the kd,l value of 2.0 (± 0.2) that was obtained when using sodium nitrate as the non-retained
species on the HSA column (see Table 1), with the two values differing by 15%. Thus, it
was concluded that differences in the rate of stagnant mobile phase mass transfer for sodium
nitrate versus L-tryptophan did not create any significant errors in the estimated dissociation
rate constants measured in this study.
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The result of this comparison is not surprising because L-tryptophan and sodium nitrate have
a similar size and both species are small compared to the pores of the support. These
properties should have given these solutes approximately the same diffusion coefficients in
the mobile phase and allowed both species to travel relatively freely between the flowing
mobile phase and stagnant mobile phase regions of the column. It should be noted, though,
that deviations in eqs 9 and 10 (or eqs 3 and 8) due to difference in the rate of stagnant
mobile phase mass transfer could become important if much larger solutes are being
examined, making restricted diffusion in the pores more important, or if there are large
differences in the sizes and diffusion coefficients of the non-retained and retained solutes. In
this situation it would advisable to simply use the same species to measure both HR and HM
through the use of an appropriate control column.
One possible issue when using separate protein and control columns to measure HR and HM
is that small differences may be created in the apparent pore diameters and values of γ · D
due to the presence and absence of the immobilized protein. The results obtained here when
using sodium nitrate on an HSA column or L-tryptophan on a control column indicate that
this issue was not a major concern for the dissociation rate constant measurements made in
this study. In addition, the plate height values for L-tryptophan and sodium nitrate that were
compared in all previous sections of this work were obtained by using only the HSA
columns, which would have automatically corrected for such an effect.
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This report examined the development of an improved, alternative method for measuring the
rates of drug-protein dissociation by using HPAC and peak profiling. This approach used
band-broadening measurements for both a retained analyte and a non-retained solute at
several flow rates on an immobilized protein column to determine the dissociation rate
constant for the analyte-protein interaction. Work with chromatographic theory was
employed to derive equations that could be used with this approach on a single column, as
well as with multiple columns to correct for the impact of stagnant mobile phase mass
transfer. This approach was tested by using the interaction of L-tryptophan with HSA as a
model, and was found to give good agreement with dissociation rate constants that were
determined by reference methods.
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The technique described in this report can be applied to other biological systems and should
be valuable for the high-throughput determination of drug-protein dissociation rates. The use
of multiple flow rates for peak profiling was found to give more robust, consistent results
than when using peak profiling at a single flow rate, while also allowing peak profiling to
conducted over a broader range of flow rate conditions.11, 58 The use of multiple columns
with different support diameters made it possible to correct for any differences in bandbroadening due to stagnant mobile phase transfer for the non-retained versus retained
solutes, as well as to examine the effects of these differences in such work. The results
obtained by this approach were comparable to values provided by previous band-broadening
studies;51,73 however, the peak profiling approach was more convenient to use and provided
estimates of kd with fewer injections and in shorter periods of time. This approach also has
several possible advantages over SPR in that it is not limited to a particular type of detection
means and kinetics can be determined for a broader range of affinity systems.35 The fact that
only a small amount of analyte is required per injection is another attractive feature of this
method. All of these properties should make this approach useful in the study of additional
solute-ligand interactions and in the high-throughput screening of solute-protein interactions
to identify or characterize new drug targets.
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NOMENCLATURE
A

Analyte

A-P

Analyte-protein complex (or analyte complex with a binding agent P)

D

Diffusion coefficient; DM and DR are the diffusion coefficients for non-retained
and retained solutes, respectively.

dp

Support particle diameter

tM

Column void time (corrected for extra column time)

tR

Retention time for an analyte on a column (corrected for extra column time)
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H

Total plate height

Hk

Plate height contribution due to stationary phase mass transfer

Hl

Plate height contribution due to longitudinal diffusion

Hm

Plate height contribution due to mobile phase mass transfer and eddy diffusion

HM

Total plate height for a non-retained species

HR

Total plate height for a retained species

Hsm

Plate height contribution due to stagnant mobile phase mass transfer

k

Retention factor

k−1

Mass transfer rate constant describing movement of a solute from the stagnant
mobile phase to the flowing mobile phase in a column

Ka

Association equilibrium constant

ka

Association rate constant

kd

Dissociation rate constant

kd,l

Dissociation rate constant, as determined using the multiple flow rate peak profiling
method

kd, s

Dissociation rate constant, as determined using peak profiling at a single linear
velocity

L

Column length

m

Slope of a linear plot to examine peak profiling data

n

Number of theoretical plates

P

Protein or binding agent

u

Linear velocity of the mobile phase

VM

Column void volume

VP

Pore volume

κ

Kinetic factor for peak profiling, as defined by eq 7

γ

Tortuosity factor

σM

Standard deviation for the peak of a non-retained species (corrected for extracolumn variance)

σR

Standard deviation for the peak of a retained species (corrected for extra-column
variance)

σM2

Peak variance for a non-retained species (corrected for extra-column variance)

σR2

Peak variance for a retained species (corrected for extra-column variance)

APPENDIX
The contributions to chromatographic efficiency are often assumed to be additive when
described in terms of variance or plate height. The total plate height for a solute eluting from
a column is typically represented as the sum of contributions due to eddy diffusion and
mobile phase mass transfer (Hm), longitudinal diffusion (Hl), stagnant mobile phase mass
transfer (Hsm), and stationary phase mass transfer (Hk),45,50
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where ti and σi represent the elution time and standard deviation for the observed peak of
solute i.
It was noted earlier that eq 3, as used in the past for peak profiling, assumes that the
difference between the total measured plate heights for a retained and non-retained species
will be equal to the plate height contribution due to stationary phase mass transfer, or (HR −
HM) = Hk.11,53,58 However, the plate height term Hsm is also known to depend on retention
and, therefore, could be quite different in size for a retained versus non-retained species. If
this is the case, the Hsm would be expected to also make up part of the difference noted in
the values of HR and HM. A better representation of (HR − HM) that accounts for this
difference is given in eq A2,
(A2)

where Hsm,R and Hsm,M are the plate height contributions due to stagnant mobile phase mass
transfer for the retained and non-retained species, respectively.
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The following general expression has been derived in previous studies to describe Hsm,60

(A3)

in which k−1 is the mass transfer rate constant that describes the movement of a solute from
the stagnant mobile phase to the flowing mobile phase region of the column. The value of
Hsm that is obtained in this case can be used to represent Hsm,R in eq A2 and in the case of a
non-retained species (for which k = 0), eq A3 reduces to Hsm,M = (2 u VP)/(k−1 VM).
Substituting eq A3 and the relationship for Hk that is given in eq 8 into eq A2 gives the
following expanded relationship.

(A4)
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Eq A4 can be simplified by factoring out (2 u VP/k−1 VM) from the two terms on the far
right-hand side of this relationship. It is assumed during this step that the mass transfer rate
constant k−1 is approximately the same for the retained and non-retained species; this is a
reasonably good assumption for low mass molecules that have similar diffusion
coefficients.60 Eq A4 can also be simplified for work with porous silica packing materials
by using the fact that VM/VP ≈ 2 for most of these supports.50 Making both of these
modifications to eq A4 produces eq A5 (Note: similar expressions can be obtained when
using values for VM/VP other than two).
(A5)
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Using the expression in eq A5, the numerator and denominator in the term on the far right
(representing the differences in Hsm for a retained versus non-retained species) can both be
multiplied by k/(1+k)2 to give eq A6.
(A6)

Cancellation of the common terms in eq A6 allows (u k)/(1+k)2 to be factored out of this
relationship, thus giving eq A7.
(A7)

This equation is now in a similar form to that shown for previously for eq 8 but no longer
makes that assumption that Hsm is the same for both the retained and non-retained species.
The difference between the new expression in eq A7 and eq 8 is that the slope term on right
has two contributing terms, one representing the contribution due to stationary phase mass
transfer and other accounting for the dependence of the stagnant mobile phase mass transfer
term on retention. The slope term of the expanded relationship in eq A7 is given by eq A8.

NIH-PA Author Manuscript

(A8)

This expression shows that it is possible to distinguish between the two sources of bandbroadening that contribute to this slope by relating the second term of eq A8 to the particle
diameter of the support. This can be accomplished by substituting into this equation the
relationship k−1 = 60 γ D/dp2, which results in eq 10.

NIH-PA Author Manuscript

An assumption made in the derivation of eqs 9 and 10 (as well as eqs 3 and 8) is that the rate
of stagnant mobile phase mass transfer is the same for the retained and non-retained species.
A similar derivation to that used to obtain eq A7 can be used to determine the effect of this
assumption. Such a derivation starts with a modified form of eq A4 in which two different
values for k−1 are used for the retained and non-retained species (i.e., k−1,R and k−1,M,
respectively. Because k−1,R and k−1,M are no longer assumed to be identical in value, as is
done in the derivation of eq 10, the only common term that can be factored out of this
modified version of eq A4 is now (2 u VP/VM). The remainder of the derivation is the same
as given earlier for eq 10. During this process, a substitution is made using the fact that k−1,R
= (60 γ DR/dp2) and k−1,M = (60 γ DM/dp2) to give the final form shown in eq 11.
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Figure 1.

Scheme for a peak profiling experiment. The various terms shown in this figure are defined
and described in the text.
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Figure 2.

Representative chromatograms for samples of (a) 25 µM L-tryptophan or (b) 25 µM sodium
nitrate injected onto an HSA column that contained a support based on 300 Å pore size, 7
µm diameter silica. These samples were injected at the indicated flow rates and at 37°C
using pH 7.4, 0.067 M potassium phosphate buffer as the mobile phase. Other conditions are
given in the text.
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Figure 3.

Typical peak profiling results for injections of 25 µM L-tryptophan or 25 µM sodium nitrate
onto an HSA column containing 7 µm diameter silica particles. The graphs in this figure
show (a) plate height plots for L-tryptophan (HR, ◆) and sodium nitrate (HM, ■); (b) a plot
of the kinetic factor κ versus linear velocity; and (c) a plot of the apparent value of kd,s for
L-tryptophan, as calculated at various linear velocities by using peak profiling method at a
single flow rate. The values for kd,s at the two lowest linear velocities in this study are not
included in (c) because these values were either much larger the other values shown or had a
negative value, as occurred in this case at the lowest flow rate, where the measured value of
HR was slightly less than HM. The error bars represent a range of ± 1 S.D.
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Figure 4.

Concentration dependence of kd,s determined for L-tryptophan using peak profiling at a
single flow rate. Data presented is for injections of L-tryptophan concentrations ranging
from 10 to 100 µM at a flow rate of 3.5 mL/min on the 7 µm HSA column. Void data for
each calculation was for injections of 25 µM sodium nitrate under the same conditions. Error
bars indicate ± 1 S.D.
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Figure 5.

Plate height curves (left) and plots of (HR − HM) versus (u k)/(1+k)2 (right) obtained for
HSA columns containing supports with particle diameters of (a) 5 µm, (b) 7 µm, or (c) 10
µm HSA columns. In the plate height curves, the total measured plate height for Ltryptophan (HR) is represented by (◆) and the total measured plate height for sodium nitrate
(HM) is represented by (■). The best fit lines for the plots of (HR − HM) versus (u k)/(1+k)2
were as follows: (a) y = 0.908 (± 0.086) x − 0.008 (± 0.001), (b) y = 1.009 (± 0.120) x −
0.010 (± 0.002), and (c) y = 1.362 (± 0.113) x − 0.008 (± 0.002), with correlation
coefficients of 0.978, 0.966, and 0.983, respectively (n = 7). The error bars represent a range
of ± 1 S.D. and are typically on the same size scale as the symbols used in these plots.
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Figure 6.

Effect of sample concentration for L-tryptophan sample on the apparent value of (HR − HM).
The concentration of sodium nitrate that was used to measure HM in these studies was 25
µM. These results were obtained at 1.0 mL/min on an HSA column that contained a 5 µm
diameter support. The error bars represent a range of ± 1 S.D.
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Figure 7.

Multi-column peak profiling graph for L-tryptophan, in which the slopes measured from the
peak profiling plots in Figure 5 were plotted versus the square of the particle diameter of the
support material within each column. The best fit line for this graph was y = 6.2 (± 0.7) x
105 x + 0.73 (± 0.04), with a correlation coefficient of 0.995 (n = 3). The error bars represent
a range of ± 1 S.D.
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Dissociation rate constants determined using different peak profiling methodsa
Measurement method
Peak profiling at a single flow rate (3.5 mL/min)b

Peak profiling at multiple flow rates (1.0–3.5 mL/min)c

Result extrapolated to dp=0 using data from multiple columnsd

Type of HSA Support

Apparent kd (s−1)

10 µm Porous silica

1.9 (± 0.2)

7 µm Porous silica

3.1 (± 0.1)

5 µm Porous silica

4.1 (± 0.2)

10 µm Porous silica

1.5 (± 0.1)

7 µm Porous silica

2.0 (± 0.2)

5 µm Porous silica

2.2 (± 0.2)

N/A

2.7 (± 0.2)

a

All of these results were obtained at 37°C in the presence of pH 7.4, 0.067 M phosphate buffer. The values in parentheses represent a range of ± 1
S.D.

b

These dissociation rate constants were calculated by using eq 3.

c

These dissociation rate constants were obtained by using eq 8.

d
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This result was obtained by using eq 10 and a plot of the slopes (from eq 9) for the multiple flow rate data versus dp2, where dp is the particle

diameter of the support material within each column.
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